Home/Filings/4/0001179110-21-002008
4//SEC Filing

OLER ABRAHAM N. 4

Accession 0001179110-21-002008

CIK 0001130598other

Filed

Feb 18, 7:00 PM ET

Accepted

Feb 19, 5:29 PM ET

Size

6.0 KB

Accession

0001179110-21-002008

Insider Transaction Report

Form 4
Period: 2021-02-17
OLER ABRAHAM N.
VP Corp Dev & Gen Counsel
Transactions
  • Award

    Stock Appreciation Right

    2021-02-17+208,000208,000 total
    Exercise: $1.51Exp: 2031-02-17Common Stock (208,000 underlying)
Footnotes (2)
  • [F1]These stock appreciation rights vest over three years, one-third on the first anniversary of the date of grant and thereafter in 24 equal monthly installments over the following two years.
  • [F2]These stock appreciation rights represent the right to receive a cash payment equal to the excess, if any, of (i) the fair market value of each underlying share of the Company's common stock, determined on the date of exercise minus (ii) the exercise price; provided, that in no event may the cash payment for each stock appreciation right exceed $1.03, which is the maximum price per share of $2.54, minus the base amount of $1.51, subject to adjustment in accordance with the terms of the award agreement.

Issuer

Onconova Therapeutics, Inc.

CIK 0001130598

Entity typeother

Related Parties

1
  • filerCIK 0001557372

Filing Metadata

Form type
4
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 5:29 PM ET
Size
6.0 KB